BackgroundInhibin subunit beta A (INHBA) is a member of the TGF-beta (transforming growth factor-beta) superfamily proteins, which plays a fundamental role in various cancers. However, there is little systematical analysis on the exact role of INHBA in patients with gastric cancer (GC). Herein, we explored the exact role and the underlying mechanisms of INHBA regarding GC using multiple bioinformatic approaches. MethodsThe expression levels of INHBA in GC were analyzed in TIMER, GEPIA2, GEO, Oncomine and UALCAN databases. Protein and PCR test were performed to verify the expression states of INHBA in GC tissues. The correlation of INHBA and prognosis of GC was analyzed based on Kaplan Meier plotter database. Besides, the relationship between INHBA expression and immune infiltration levels and the type markers of immune cells in GC was explored in the TIMER database. What’s more, we studied INHBA mutations, promoter methylation, functional enrichment analysis in GC patients based on cBioportal, MEXPRESS, Metascape and LinkedOmics databases. Besides, we performed immunohistochemistry (IHC) and polymerase chain reaction (qRT-PCR ) verification in tissues from patients with gastric cancerResultsINHBA was elevated in GC and high expression level of INHBA in GC was significantly related to the unfavorable prognosis. Protein and PCR test verified the highly expression states of INHBA in GC tissues. Further analysis showed that INHBA was negatively correlated with B cell while positively correlated with the marker type of CD8+ T cells, macrophage, neutrophil and dendritic cell infiltration. High INHBA expression level had a poor prognosis in different enriched immune cells subgroups in GC. And there is week significant methylation level change between tumor and normal tissues. Moreover, INHBA mainly enriched cancer-related signaling pathways, including TGF-beta signaling pathway, ECM-receptor signaling pathway, PID ALK1/2 pathway, and AGE-RAGE signaling pathway. ConclusionsThe present study implies that INHBA may serve as a potential biomarkers for predicting prognosis in GC patients. High INHBA expression in GC may affect prognosis through immune infiltration.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.